ARTRYL CAP 200 MG 200 MG — DIN 02089440
VALERIAN : 200 MG · LES LABORATOIRES VACHON INC. · CAPSULE · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is ARTRYL CAP 200 MG?
ARTRYL CAP 200 MG 200 MG contains VALERIAN : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02089440, held by LES LABORATOIRES VACHON INC., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 12-Jul-2007. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Valerianae Radix in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Valerianae Radix, across 10 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| ASHBURY RESEARCH CORPORATION | 1 | 0 | ETHICAL HERBALS SLEEP AID | No marketed DIN |
| GAMME NATURE | 1 | 0 | VALERIANE | No marketed DIN |
| HERMES ARZNEIMITTEL GMBH | 1 | 0 | HERMES NO6 TEA | No marketed DIN |
| HOLISTA HEALTH (CANADA) INC. | 1 | 0 | VALERIAN | No marketed DIN |
| LABORATOIRE LALCO INC. | 1 | 0 | FACILITE LE SOMMEIL - CAP 270MG | No marketed DIN |
| LABORATOIRES CHARTON LABORATORIES | 1 | 0 | EFFIDOSE VALERIANE LIQ 1916MG/10ML AMP | No marketed DIN |
| LES LABORATOIRES VACHON INC. | 1 | 0 | ARTRYL CAP 200 MG | No marketed DIN |
| PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | 1 | 0 | UNISOM NATURAL SOURCE | No marketed DIN |
| RHEINGOLD FOOD INTERNATIONAL LTD. | 1 | 0 | KALM CAPS | No marketed DIN |
| SANTÉ NATURELLE (AG) LTÉE | 1 | 0 | PHYTOCALM | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 200 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Valerianae Radix |
|---|---|
| ATC code | N05CM09 |
| AHFS class | 92:01.00* ; See footnote |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02089440 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2089440 |
| Brand name | ARTRYL CAP 200 MG |
| Generic / active ingredient | VALERIAN : 200 MG |
| Market authorization holder | LES LABORATOIRES VACHON INC. |
| Health Canada schedule | NON-PRESCRIPTION DRUGS |
| ATC code | N05CM09 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05CM |
| Current status | CANCELLED POST MARKET |
| Status date | 12-Jul-2007 |
| Original market date | 1994-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
0 of 10 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| EFFIDOSE VALERIANE LIQ 1916MG/10ML AMP | 1.916 G | LIQUID | LABORATOIRES CHARTON LABORATORIES | CANCELLED POST MARKET | 02052539 |
| ETHICAL HERBALS SLEEP AID | 170 MG | TABLET | ASHBURY RESEARCH CORPORATION | CANCELLED PRE MARKET | 02239995 |
| FACILITE LE SOMMEIL - CAP 270MG | 270 MG | CAPSULE | LABORATOIRE LALCO INC. | CANCELLED POST MARKET | 02228068 |
| HERMES NO6 TEA | 120 MG / 5 ML | TEA (HERBAL) | HERMES ARZNEIMITTEL GMBH | CANCELLED POST MARKET | 00439754 |
| KALM CAPS | 175 MG | CAPSULE | RHEINGOLD FOOD INTERNATIONAL LTD. | CANCELLED POST MARKET | 00628980 |
| PHYTOCALM | 150 MG | CAPSULE | SANTÉ NATURELLE (AG) LTÉE | CANCELLED POST MARKET | 02238752 |
| UNISOM NATURAL SOURCE | 400 MG | CAPSULE | PFIZER CANADA INC., CONSUMER HEALTHCARE DIVISION | CANCELLED POST MARKET | 02238837 |
| VALERIAN | 300 MG | CAPSULE | HOLISTA HEALTH (CANADA) INC. | CANCELLED POST MARKET | 02246073 |
| VALERIANE | 140 MG | TABLET | GAMME NATURE | CANCELLED POST MARKET | 00794481 |
2 · Same class — other molecules in ATC N05CM
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Dexmedetomidine | DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION · DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION USP · DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP · DEXMEDETOMIDINE HYDROCHLORIDE INJECTION · +1 more | 16 | 9 | Yes |
| Scopolamine | SCOPOLAMINE HYDROBROMIDE INJECTION | 2 | 2 | Yes |
| Valerianae Radix | ARTRYL CAP 200 MG · EFFIDOSE VALERIANE LIQ 1916MG/10ML AMP · ETHICAL HERBALS SLEEP AID · FACILITE LE SOMMEIL - CAP 270MG · +6 more | 10 | 0 | Not in Canada |
| Ethchlorvynol | PLACIDYL CAP 200MG · PLACIDYL CAP 500MG · PLACIDYL CAP 750MG | 3 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N05C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N05CF | Eszopiclone · Zaleplon · Zolpidem · Zopiclone | 125 | 57 |
| N05CD | Estazolam · Flurazepam · Midazolam · Nitrazepam · Temazepam · +1 more | 108 | 21 |
| N05CC | Chloral Hydrate · Paraldehyde | 9 | 1 |
| N05CJ | Daridorexant · Suvorexant | 6 | 1 |
| N05CA | Amobarbital · Barbiturates, Plain · Pentobarbital · Secobarbital | 14 | 0 |
| N05CB | Combinations Of Barbiturates | 2 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.